Corrigendum to “The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement” [Leukemia Res. 100 (2021) 106480] (Leukemia Research (2021) 100, (S0145212620301855), (10.1016/j.leukres.2020.106480))

Colin P. Bergstrom, Saurabh Dahiya, Weina Chen, Cheng Cheng Zhang, Hong Zhu, Jingsheng Yan, Yazan Madanat, Prapti Patel, Madhuri Vusirkala, Praveen Ramakrishnan, Syed Rizvi, Stephen Chung, Farrukh Awan, Larry D. Anderson, Robert Collins, Ankit Kansagra

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors would like to include the conflict of interest statement of Cheng Cheng Zhang, who had patent applications licensed to, holds equity in, has a sponsored research agreement with, and is a Scientific Advisory Board member with Immune-Onc Therapeutics. The authors would like to apologise for any inconvenience caused.

Original languageEnglish (US)
Article number106563
JournalLeukemia Research
Volume104
DOIs
StatePublished - May 2021
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Corrigendum to “The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement” [Leukemia Res. 100 (2021) 106480] (Leukemia Research (2021) 100, (S0145212620301855), (10.1016/j.leukres.2020.106480))'. Together they form a unique fingerprint.

Cite this